The safety of breast-conserving therapy in patients with breast cancer aged <or = 40 years

M. van der Leest; L.J.M. Evers; M.J.C. Van der Sangen; P.M. Poortmans; L.V. van de Poll-Franse; A.J. Vulto; G.A.P. Nieuwenhuijzen; S.J. Brenninkmeijer; G.J. Creemers; A.C. Voogd

doi:10.1002/cncr.22639

The safety of breast-conserving therapy in patients with breast cancer aged <or = 40 years

M. van der Leest, L.J.M. Evers, M.J.C. Van der Sangen, P.M. Poortmans, L.V. van de Poll-Franse, A.J. Vulto, G.A.P. Nieuwenhuijzen, S.J. Brenninkmeijer, G.J. Creemers, A.C. Voogd^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

BACKGROUND. The objectives of this study were to study the probability of local control after breast-conserving therapy (BCT) in a large population of patients with early-stage breast cancer aged 50%. CONCLUSIONS. The risk of local recurrence in young patients who underwent BCT was reduced strongly by using adjuvant systemic treatment. This finding may provide an argument if favor of advising the use of systemic treatment for all patients aged

Original language	English
Pages (from-to)	1957-64
Journal	Cancer
Volume	109
Issue number	10
DOIs	https://doi.org/10.1002/cncr.22639
Publication status	Published - 1 Jan 2007

Access to Document

10.1002/cncr.22639

Cite this

@article{d3903a6dcbc04a858cadcc4e933f5740,

title = "The safety of breast-conserving therapy in patients with breast cancer aged <or = 40 years",

abstract = "BACKGROUND. The objectives of this study were to study the probability of local control after breast-conserving therapy (BCT) in a large population of patients with early-stage breast cancer aged 50%. CONCLUSIONS. The risk of local recurrence in young patients who underwent BCT was reduced strongly by using adjuvant systemic treatment. This finding may provide an argument if favor of advising the use of systemic treatment for all patients aged ",

author = "{van der Leest}, M. and L.J.M. Evers and {Van der Sangen}, M.J.C. and P.M. Poortmans and {van de Poll-Franse}, L.V. and A.J. Vulto and G.A.P. Nieuwenhuijzen and S.J. Brenninkmeijer and G.J. Creemers and A.C. Voogd",

year = "2007",

month = jan,

day = "1",

doi = "10.1002/cncr.22639",

language = "English",

volume = "109",

pages = "1957--64",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley & Sons Inc.",

number = "10",

}

TY - JOUR

T1 - The safety of breast-conserving therapy in patients with breast cancer aged <or = 40 years

AU - van der Leest, M.

AU - Evers, L.J.M.

AU - Van der Sangen, M.J.C.

AU - Poortmans, P.M.

AU - van de Poll-Franse, L.V.

AU - Vulto, A.J.

AU - Nieuwenhuijzen, G.A.P.

AU - Brenninkmeijer, S.J.

AU - Creemers, G.J.

AU - Voogd, A.C.

PY - 2007/1/1

Y1 - 2007/1/1

N2 - BACKGROUND. The objectives of this study were to study the probability of local control after breast-conserving therapy (BCT) in a large population of patients with early-stage breast cancer aged 50%. CONCLUSIONS. The risk of local recurrence in young patients who underwent BCT was reduced strongly by using adjuvant systemic treatment. This finding may provide an argument if favor of advising the use of systemic treatment for all patients aged

AB - BACKGROUND. The objectives of this study were to study the probability of local control after breast-conserving therapy (BCT) in a large population of patients with early-stage breast cancer aged 50%. CONCLUSIONS. The risk of local recurrence in young patients who underwent BCT was reduced strongly by using adjuvant systemic treatment. This finding may provide an argument if favor of advising the use of systemic treatment for all patients aged

U2 - 10.1002/cncr.22639

DO - 10.1002/cncr.22639

M3 - Article

C2 - 17394192

SN - 0008-543X

VL - 109

SP - 1957

EP - 1964

JO - Cancer

JF - Cancer

IS - 10

ER -

The safety of breast-conserving therapy in patients with breast cancer aged <or = 40 years

Abstract

Access to Document

Fingerprint

Cite this